Skip to main content
Top
Published in: Digestive Diseases and Sciences 9/2016

01-09-2016 | Editorial

Nonalcoholic Fatty Liver Disease in Patients with Autoimmune Hepatitis: Further Reason for Teeth GNASHing?

Authors: Christina Weiler-Normann, Ansgar W. Lohse

Published in: Digestive Diseases and Sciences | Issue 9/2016

Login to get access

Excerpt

Nonalcoholic steatohepatitis (NASH), the aggressive form of nonalcoholic fatty liver disease (NAFLD), is a public health burden of increasing significance associated with significant liver-related and -unrelated morbidity and mortality [1]. Predisposing factors, apart from a partially defined genetic predisposition, include the presence of diabetes or pre-diabetes, hyperlipidemia, obesity, and lack of physical activity and exercise. This emerging disease, largely unknown only few decades ago, has developed into a worldwide health epidemic affecting not only 10–30 % of the Western population, but also increasing portions of populations in other parts of the world, including developing countries. …
Literature
1.
go back to reference European Association for the Study of the Liver. Clinical practice guidelines for the management of nonalcoholic fatty liver disease. J Hepatol. 2016;64:1388–1402.CrossRef European Association for the Study of the Liver. Clinical practice guidelines for the management of nonalcoholic fatty liver disease. J Hepatol. 2016;64:1388–1402.CrossRef
2.
go back to reference De Luca-Johnson J, Wangensteen KJ, Hanson J, Krawitt EL, Wilcox R. Natural history of patients presenting with autoimmune hepatitis and coincident nonalcoholic fatty liver disease. Dig Dis Sci. (Epub ahead of print). doi:10.1007/s10620-016-4213-3. De Luca-Johnson J, Wangensteen KJ, Hanson J, Krawitt EL, Wilcox R. Natural history of patients presenting with autoimmune hepatitis and coincident nonalcoholic fatty liver disease. Dig Dis Sci. (Epub ahead of print). doi:10.​1007/​s10620-016-4213-3.
3.
go back to reference Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169–176.CrossRefPubMed Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169–176.CrossRefPubMed
4.
go back to reference European Association for the Study of the Liver. Clinical practice guidelines: autoimmune hepatitis. J Hepatol. 2015;63:971–1004.CrossRef European Association for the Study of the Liver. Clinical practice guidelines: autoimmune hepatitis. J Hepatol. 2015;63:971–1004.CrossRef
5.
go back to reference Dyal HK, Aguilar M, Bhuket T, et al. Concurrent obesity, diabetes, and steatosis increase risk of advanced fibrosis among HCV patients: a systematic review. Dig Dis Sci. 2015;60:2813–2824.CrossRefPubMed Dyal HK, Aguilar M, Bhuket T, et al. Concurrent obesity, diabetes, and steatosis increase risk of advanced fibrosis among HCV patients: a systematic review. Dig Dis Sci. 2015;60:2813–2824.CrossRefPubMed
6.
go back to reference Schramm C, Kanzler S, Zum Buschenfelde KH, Galle PR, Lohse AW. Autoimmune hepatitis in the elderly. Am J Gastroenterol. 2001;96:1587–1591.CrossRefPubMed Schramm C, Kanzler S, Zum Buschenfelde KH, Galle PR, Lohse AW. Autoimmune hepatitis in the elderly. Am J Gastroenterol. 2001;96:1587–1591.CrossRefPubMed
7.
go back to reference Manns MP, Czaja AJ, Gorham JD, et al. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010;51:2193–2213.CrossRefPubMed Manns MP, Czaja AJ, Gorham JD, et al. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010;51:2193–2213.CrossRefPubMed
Metadata
Title
Nonalcoholic Fatty Liver Disease in Patients with Autoimmune Hepatitis: Further Reason for Teeth GNASHing?
Authors
Christina Weiler-Normann
Ansgar W. Lohse
Publication date
01-09-2016
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 9/2016
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-016-4258-3

Other articles of this Issue 9/2016

Digestive Diseases and Sciences 9/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.